AN2 Therapeutics
ANTX
ANTX
36 hedge funds and large institutions have $92.9M invested in AN2 Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 23 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
44% less capital invested
Capital invested by funds: $165M → $92.9M (-$72.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.86M | |
| 2 | +$2.45M | |
| 3 | +$2.06M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$413K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$379K |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$546K | |
| 3 | -$502K | |
| 4 |
Renaissance Technologies
New York
|
-$382K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$299K |